Skip to main content

Point72 Asset Management, L.P.

Position in TERN — Terns Pharmaceuticals, Inc.

CIK 1603466 STAMFORD, CT

Position in TERN

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$0
+$0 QoQ
Shares Held
0
-100.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2022
12 quarters on record

Common Shares in TERN Over Time

Shares Held

Position Value (USD)

Derivatives in TERN

reported options exposure · as of Mar 31, 2026
CallValue
$0
CallShares
4,300
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Point72 Asset Management, L.P. holds $2,243,264,515 across 171 Biotechnology names.

# Ticker Company Shares Value (USD) Open

All Filings in TERN

Export CSV
12 filing rows on record
Report Date Value (USD) Shares
2026-03-31 4,300
2025-12-31 573,700
2025-03-31 160,725
2024-12-31 1,251,841
2024-09-30 2,707,515
2024-06-30 2,690,376
2024-03-31 2,221,200
2023-09-30 571,265
2023-03-31 629,098
2022-12-31 233,500
2022-06-30 500,000
2022-03-31 122,573